Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

Acoramidis Halves Cumulative CV Events Within 6 Months: ATTRibute-CM

News Conference News HFSA 2025

Acoramidis Halves Cumulative CV Events Within 6 Months: ATTRibute-CM

Yael L. Maxwell

October 01, 2025

Voice Analysis Picks Up Patients at Risk for HF Hospitalization: COMMUNITY-HF

News Conference News HFSA 2025

Voice Analysis Picks Up Patients at Risk for HF Hospitalization: COMMUNITY-HF

Yael L. Maxwell

September 29, 2025

‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM

News Conference News HFSA 2024

‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM

October 02, 2024

Innovation in Heart Donation, Preservation Set to Shake Up Allocation

News Conference News HFSA 2023

Innovation in Heart Donation, Preservation Set to Shake Up Allocation

October 18, 2023

REBALANCE-HF Uncovers HFpEF Group That Responds to Splanchnic Nerve Ablation

News Conference News HFSA 2023

REBALANCE-HF Uncovers HFpEF Group That Responds to Splanchnic Nerve Ablation

October 11, 2023

REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status

News Conference News HFSA 2022

REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status

October 07, 2022

GDMT With ARNI Lessens MR, Perhaps Obviating Need for Interventions

News Conference News HFSA 2022

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

Michael O'Riordan

October 04, 2022

EMBRACE HF: Empagliflozin Cuts PA Pressure in HF With or Without Diabetes

News Conference News HFSA 2020

EMBRACE HF: Empagliflozin Cuts PA Pressure in HF With or Without Diabetes

October 09, 2020

New PROVE-HF Data May Reassure Clinicians of Sacubitril/Valsartan Benefit in HFrEF

News Conference News HFSA 2019

New PROVE-HF Data May Reassure Clinicians of Sacubitril/Valsartan Benefit in HFrEF

September 18, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.